Analysis of the Dynamics of Clinical Parameters and Serum Angiogenic Factors in Systemic Sclerosis Patients Undergoing Tocilizumab Treatment
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yuichiro Segawa, Takehiro Takahashi, Takuya Takahashi, Kenta Oka, Yumi Kambayashi, Toshiya Takahashi, Yoshihide Asano |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis
by: Takuya Takahashi, et al.
Published: (2024)
by: Takuya Takahashi, et al.
Published: (2024)
A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab
by: Yuichiro Segawa, et al.
Published: (2025)
by: Yuichiro Segawa, et al.
Published: (2025)
Comprehensive Analysis of the Chemokine/Cytokine Profiles in Advanced Mycosis Fungoides and Atopic Dermatitis
by: Manami Takahashi-Watanabe, et al.
Published: (2025)
by: Manami Takahashi-Watanabe, et al.
Published: (2025)
Eosinophilic annular erythema successfully treated with dupilumab: A case report
by: Toshiki Okazaki, et al.
Published: (2024)
by: Toshiki Okazaki, et al.
Published: (2024)
Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute‐on‐chronic pancreatitis: A case report
by: Toshiki Okazaki, et al.
Published: (2024)
by: Toshiki Okazaki, et al.
Published: (2024)
Successful Control of Langer hans Cell Sarcoma in a Super‐Aged Patient Using Intensity‐Modulated Radiotherapy
by: Hiromu Okuguchi, et al.
Published: (2026)
by: Hiromu Okuguchi, et al.
Published: (2026)
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment
by: Ryo Amagai, et al.
Published: (2025)
by: Ryo Amagai, et al.
Published: (2025)
Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
by: Toshiki Okazaki, et al.
Published: (2025)
by: Toshiki Okazaki, et al.
Published: (2025)
Long‐Term Real‐World Outcomes of Baricitinib in Severe Alopecia Areata: A 104‐Week Retrospective Analysis From a Single Institute
by: Moyuka Wada‐Irimada, et al.
Published: (2025)
by: Moyuka Wada‐Irimada, et al.
Published: (2025)
A Japanese Case of Marie Unna Hereditary Hypotrichosis With a HRURF Gene Variant
by: Jun Yamamoto, et al.
Published: (2026)
by: Jun Yamamoto, et al.
Published: (2026)
Coronary Artery Disease Assessment in Psoriasis Patients Well‐Controlled Under Systemic Anti‐Inflammatory Treatments—A Real‐World Observational Study From a Single Center
by: Toshiki Okazaki, et al.
Published: (2025)
by: Toshiki Okazaki, et al.
Published: (2025)
A Case of Taxane‐Induced Scleroderma Presenting in a Unilateral Upper Limb and a Literature Review
by: Mana Sekine, et al.
Published: (2025)
by: Mana Sekine, et al.
Published: (2025)
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol
by: Taku Fujimura, et al.
Published: (2026)
by: Taku Fujimura, et al.
Published: (2026)
Serum Nectin‐4 as a Potential Prognostic Biomarker for Extramammary Paget Disease
by: Hiromichi Morita, et al.
Published: (2025)
by: Hiromichi Morita, et al.
Published: (2025)
Toll‐like receptor 2 activation induces C‐C motif chemokine ligand 5 production in canine keratinocytes
by: Kaho Takahashi, et al.
Published: (2025)
by: Kaho Takahashi, et al.
Published: (2025)
Successful treatment of Darier's disease with apremilast and review of reported cases
by: Yusuke Muto, et al.
Published: (2024)
by: Yusuke Muto, et al.
Published: (2024)
Refractory acrodermatitis continua of Hallopeau successfully treated by baricitinib: A case report
by: Yusuke Muto, et al.
Published: (2024)
by: Yusuke Muto, et al.
Published: (2024)
A 104‐Week Real‐World Outcome of Bimekizumab Treatment for Psoriasis: Biologic‐Naïve Versus ‐Experienced Patients
by: Yohei Takahashi, et al.
Published: (2025)
by: Yohei Takahashi, et al.
Published: (2025)
Early‐Stage Limited Cutaneous Systemic Sclerosis Successfully Treated With Guselkumab: Possibility of Early Intervention in the Pathogenesis
by: Shingo Hirano, et al.
Published: (2025)
by: Shingo Hirano, et al.
Published: (2025)
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan
by: Wataru Sasaki, et al.
Published: (2025)
by: Wataru Sasaki, et al.
Published: (2025)
Serum Anti‐Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real‐World Clinical Practice: A Single‐Center Retrospective Study
by: Hiroyoshi Nozaki, et al.
Published: (2025)
by: Hiroyoshi Nozaki, et al.
Published: (2025)
Serum TARC Levels Reflect the Severity and Prognosis of Atopic Dermatitis in Infants Under 6 Months of Age: A Retrospective Study in a Pediatric Primary Care Practice
by: Yumi Yamada, et al.
Published: (2026)
by: Yumi Yamada, et al.
Published: (2026)
Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma
by: Mayuko Yamamoto, et al.
Published: (2024)
by: Mayuko Yamamoto, et al.
Published: (2024)
Bullous Rheumatoid Neutrophilic Dermatitis in a Juvenile Idiopathic Arthritis Patient Treated With Tocilizumab
by: Yoshiharu Kubota, et al.
Published: (2026)
by: Yoshiharu Kubota, et al.
Published: (2026)
Effectiveness of Apremilast in Patients With Palmoplantar Pustulosis: A 28‐Week Real‐World Study
by: Yohei Takahashi, et al.
Published: (2026)
by: Yohei Takahashi, et al.
Published: (2026)
Exposure Data of Cosmetic Products for Patients Undergoing Cancer Treatment
by: Pauline Roch‐Simon, et al.
Published: (2025)
by: Pauline Roch‐Simon, et al.
Published: (2025)
Circulating Interleukin‐6 and Janus Kinase 2 DNA Copies in Serum Cell‐Free DNA Are Elevated in Patients With Systemic Sclerosis
by: Hitomi Matsunaga‐Nakashima, et al.
Published: (2025)
by: Hitomi Matsunaga‐Nakashima, et al.
Published: (2025)
The Maintenance of Early Responses and Achievement of Delayed Responses to Deucravacitinib Treatment in Psoriais: A 104‐Week Real‐World Study in Japan
by: Hiroki Usuki, et al.
Published: (2026)
by: Hiroki Usuki, et al.
Published: (2026)
Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series
by: Takeya Adachi, et al.
Published: (2024)
by: Takeya Adachi, et al.
Published: (2024)
Human Papilloma Virus Type 94–Associated Flat Warts Developing Repeatedly During Tofacitinib Treatment: A Case Report and Review
by: Nobuhiro Takahashi, et al.
Published: (2025)
by: Nobuhiro Takahashi, et al.
Published: (2025)
A Case of Bullous Pemphigoid in a Patient With Systemic Sarcoidosis and Relapsing Polychondritis
by: Takehiro Nakamura, et al.
Published: (2025)
by: Takehiro Nakamura, et al.
Published: (2025)
Primary localized cutaneous nodular amyloidosis of the scalp arising from folliculitis decalvans
by: Honoka Takahashi, et al.
Published: (2024)
by: Honoka Takahashi, et al.
Published: (2024)
Tocilizumab for severe and refractory mucous membrane pemphigoid
by: Billal Tedbirt, et al.
Published: (2026)
by: Billal Tedbirt, et al.
Published: (2026)
Two‐Year Real‐World Effectiveness of Deucravacitinib in Psoriasis: The Analysis Stratified by Prior Apremilast or Biologic Therapy
by: Ryo Ishihara, et al.
Published: (2026)
by: Ryo Ishihara, et al.
Published: (2026)
Real‐World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program ( EAP )
by: Akimichi Morita, et al.
Published: (2025)
by: Akimichi Morita, et al.
Published: (2025)
A Distinctive Plaque in a Tuberous Sclerosis Patient
by: Hitaishi Mehta, et al.
Published: (2025)
by: Hitaishi Mehta, et al.
Published: (2025)
Two‐Year Real‐World Effectiveness of Deucravacitinib 6 mg in Psoriasis: A Single‐Center Analysis Stratified by Body Mass Index or Age in a Japanese Cohort
by: Yuriko Okabe, et al.
Published: (2026)
by: Yuriko Okabe, et al.
Published: (2026)
Acute compartment syndrome caused by box jellyfish (habu‐kurage) stings: Report of a 7‐year‐old patient
by: Shizuki Shimoji, et al.
Published: (2024)
by: Shizuki Shimoji, et al.
Published: (2024)
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review
by: Conor Larney, et al.
Published: (2025)
by: Conor Larney, et al.
Published: (2025)
Phaeoacremonium alvesii Infection in an Immunocompromised Patient: A Case Report
by: Yumi Hanatani, et al.
Published: (2025)
by: Yumi Hanatani, et al.
Published: (2025)
Similar Items
-
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis
by: Takuya Takahashi, et al.
Published: (2024) -
A case of systemic sclerosis accompanying psoriasis successfully treated with brodalumab
by: Yuichiro Segawa, et al.
Published: (2025) -
Comprehensive Analysis of the Chemokine/Cytokine Profiles in Advanced Mycosis Fungoides and Atopic Dermatitis
by: Manami Takahashi-Watanabe, et al.
Published: (2025) -
Eosinophilic annular erythema successfully treated with dupilumab: A case report
by: Toshiki Okazaki, et al.
Published: (2024) -
Pancreatitis, panniculitis, and polyarthritis (PPP) syndrome associated with acute‐on‐chronic pancreatitis: A case report
by: Toshiki Okazaki, et al.
Published: (2024)